Study involves healthy employees at high risk for future sickness absence.
Conditions
Interventions
The effectiveness of early intervention among employees at high risk for sickness absence will be determined by means of a randomised controlled trial, with an initial total follow-up period of 12 mon
Sponsors
- Department of Epidemiology, Maastricht University, Maastricht
- ABN AMRO Arbo Services, Amsterdam
Eligibility
Inclusion criteria
Inclusion criteria: Employees at high risk for future long-term sickness absence as identified by a validated screening questionnaire called "Balansmeter".
Exclusion criteria
Exclusion criteria: 1. Employees on sick leave; 2. Pregnant employees; 3. Treatment/guidance by occupational physician.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary outcome is sickness absence. All information regarding sickness absence will be gathered through record linkage on an individual level with the company register on sickness absence. Sickness absence measures include absence frequency, time to onset of first absence spell, and sickness absence duration. Sickness absence will be assessed during the complete follow-up period of 12 months. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcome measures will be assessed at baseline and during follow-up by means of questionnaires. Secondary outcomes include (mental) health status, capturing amongst others need for recovery from work, prolonged fatigue, and psychological distress), and working conditions, such as for example social support from supervisor and colleagues, psychological job demands, decision latitude, and working hours. Additionally medical consumption will be inventoried. Follow-up measurements will take place at 6 and 12 months after randomisation. | — |
Contacts
Public ContactN.W.H. Jansen
University Maastricht (UM), Department of Epidemiology, P.O. Box 616
Outcome results
None listed